Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.